Simmie Lorene Foster, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammasomes | 1 | 2023 | 525 | 0.600 |
Why?
|
Nociceptors | 5 | 2022 | 461 | 0.560 |
Why?
|
Sensory Receptor Cells | 4 | 2024 | 513 | 0.440 |
Why?
|
Ketamine | 3 | 2022 | 519 | 0.360 |
Why?
|
Central Nervous System Diseases | 1 | 2015 | 520 | 0.360 |
Why?
|
Yoga | 2 | 2024 | 281 | 0.350 |
Why?
|
Interleukins | 1 | 2015 | 782 | 0.350 |
Why?
|
Depressive Disorder, Major | 6 | 2024 | 4760 | 0.340 |
Why?
|
Neuroglia | 1 | 2015 | 955 | 0.320 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 11902 | 0.310 |
Why?
|
Toll-Like Receptor 4 | 2 | 2019 | 579 | 0.250 |
Why?
|
Toll-Like Receptors | 1 | 2008 | 589 | 0.240 |
Why?
|
Recovery of Function | 1 | 2015 | 2977 | 0.240 |
Why?
|
Depression | 6 | 2024 | 8122 | 0.210 |
Why?
|
Receptors, Interleukin-6 | 1 | 2024 | 225 | 0.210 |
Why?
|
Inflammation | 6 | 2024 | 10762 | 0.200 |
Why?
|
Heat-Shock Response | 1 | 2023 | 179 | 0.200 |
Why?
|
Neuroimmunomodulation | 3 | 2024 | 181 | 0.200 |
Why?
|
Vagus Nerve | 2 | 2021 | 458 | 0.180 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.170 |
Why?
|
Hallucinogens | 1 | 2023 | 197 | 0.170 |
Why?
|
Riluzole | 1 | 2019 | 59 | 0.160 |
Why?
|
Hypersensitivity | 2 | 2021 | 1158 | 0.160 |
Why?
|
Receptors, IgE | 1 | 2021 | 374 | 0.160 |
Why?
|
Metaplasia | 1 | 2020 | 322 | 0.160 |
Why?
|
Peripheral Nervous System | 1 | 2019 | 151 | 0.150 |
Why?
|
Mucus | 1 | 2020 | 341 | 0.150 |
Why?
|
Respiratory Mucosa | 1 | 2021 | 439 | 0.140 |
Why?
|
Infrared Rays | 1 | 2018 | 247 | 0.140 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2018 | 189 | 0.140 |
Why?
|
Immunoglobulin E | 1 | 2021 | 1495 | 0.120 |
Why?
|
Chromatin | 1 | 2007 | 2960 | 0.120 |
Why?
|
Cytokines | 4 | 2024 | 7392 | 0.120 |
Why?
|
Airway Remodeling | 1 | 2015 | 133 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2024 | 3207 | 0.110 |
Why?
|
Respiratory Hypersensitivity | 1 | 2015 | 273 | 0.110 |
Why?
|
Macrophages | 2 | 2023 | 5768 | 0.100 |
Why?
|
Metabolic Diseases | 1 | 2018 | 681 | 0.100 |
Why?
|
Antidepressive Agents | 2 | 2024 | 2897 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2020 | 1398 | 0.090 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1444 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4575 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4764 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7584 | 0.070 |
Why?
|
Animals | 9 | 2023 | 168441 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2018 | 2637 | 0.070 |
Why?
|
Mice | 6 | 2023 | 81509 | 0.070 |
Why?
|
Immunity, Innate | 3 | 2020 | 3061 | 0.070 |
Why?
|
Ovalbumin | 2 | 2021 | 677 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2022 | 2218 | 0.070 |
Why?
|
Signal Transduction | 2 | 2024 | 23441 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5709 | 0.060 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2023 | 47 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2024 | 12330 | 0.050 |
Why?
|
Genes, RAG-1 | 1 | 2022 | 67 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4477 | 0.050 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2007 | 633 | 0.050 |
Why?
|
Euphoria | 1 | 2022 | 65 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8596 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2024 | 64651 | 0.050 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.050 |
Why?
|
Pain | 1 | 2016 | 5071 | 0.050 |
Why?
|
Body Temperature | 1 | 2024 | 782 | 0.040 |
Why?
|
Neurites | 1 | 2022 | 391 | 0.040 |
Why?
|
Hyperthermia, Induced | 1 | 2024 | 417 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 39975 | 0.040 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2022 | 323 | 0.040 |
Why?
|
Thermoreceptors | 1 | 2019 | 27 | 0.040 |
Why?
|
Substance P | 1 | 2021 | 335 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2207 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2022 | 560 | 0.040 |
Why?
|
Humans | 18 | 2024 | 761423 | 0.040 |
Why?
|
Serotonin | 1 | 2023 | 1042 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 477 | 0.040 |
Why?
|
HMGB1 Protein | 1 | 2019 | 137 | 0.040 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2020 | 448 | 0.040 |
Why?
|
Male | 9 | 2024 | 360736 | 0.040 |
Why?
|
Toll-Like Receptor 2 | 1 | 2019 | 347 | 0.040 |
Why?
|
Models, Genetic | 1 | 2007 | 3446 | 0.040 |
Why?
|
Histones | 1 | 2007 | 2580 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1090 | 0.030 |
Why?
|
Female | 9 | 2024 | 392581 | 0.030 |
Why?
|
Fever | 1 | 2024 | 1618 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2019 | 859 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5789 | 0.030 |
Why?
|
Peripheral Nerves | 1 | 2019 | 479 | 0.030 |
Why?
|
Adult | 7 | 2024 | 221148 | 0.030 |
Why?
|
Freund's Adjuvant | 1 | 2015 | 149 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2018 | 551 | 0.030 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2015 | 180 | 0.030 |
Why?
|
Brain | 2 | 2018 | 27107 | 0.030 |
Why?
|
Exosomes | 1 | 2019 | 424 | 0.030 |
Why?
|
Interleukin-5 | 1 | 2015 | 269 | 0.030 |
Why?
|
Capsaicin | 1 | 2015 | 231 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1674 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2018 | 700 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1793 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7595 | 0.030 |
Why?
|
Allergens | 1 | 2021 | 1410 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 220826 | 0.030 |
Why?
|
Reaction Time | 1 | 2019 | 2080 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1472 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15498 | 0.030 |
Why?
|
Self Report | 1 | 2024 | 3724 | 0.030 |
Why?
|
Outpatients | 1 | 2020 | 1597 | 0.030 |
Why?
|
Lidocaine | 1 | 2015 | 538 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2022 | 2218 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2007 | 18964 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4852 | 0.020 |
Why?
|
Biopsy | 1 | 2022 | 6766 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1886 | 0.020 |
Why?
|
Drug Hypersensitivity | 1 | 2019 | 917 | 0.020 |
Why?
|
Neuropeptides | 1 | 2016 | 944 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2015 | 2065 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2677 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18247 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1651 | 0.020 |
Why?
|
Cell Communication | 1 | 2016 | 1657 | 0.020 |
Why?
|
Survival Rate | 1 | 2022 | 12720 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 997 | 0.020 |
Why?
|
Autoimmunity | 1 | 2016 | 1355 | 0.020 |
Why?
|
Calcium | 1 | 2021 | 5727 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8832 | 0.020 |
Why?
|
Young Adult | 2 | 2024 | 59207 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3874 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2509 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14409 | 0.020 |
Why?
|
Homeostasis | 1 | 2016 | 3321 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10498 | 0.010 |
Why?
|
Adolescent | 2 | 2024 | 88313 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29620 | 0.010 |
Why?
|
Neurons | 1 | 2021 | 9462 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22163 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15717 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9995 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17912 | 0.010 |
Why?
|
Aged | 2 | 2024 | 169235 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29862 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80582 | 0.010 |
Why?
|
Neoplasms | 1 | 2019 | 22164 | 0.010 |
Why?
|